Last reviewed · How we verify

NCT03306017: DAV-Hémo

Effects of Left Ventricular Assist Device Implantation on the Phenotype of Blood Platelets and Leucocytes

Completed NA Last updated 20 August 2019
What this trial tests

NA trial testing Blood sampling in Cardiac Insufficiency in 4 participants. Completed in 23 January 2019.

Timeline
3 October 2017
Primary endpoint
23 August 2018
23 January 2019

Quick facts

Lead sponsorUniversity Hospital, Toulouse
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment4
Start date3 October 2017
Primary completion23 August 2018
Estimated completion23 January 2019
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Toulouse

Who can join

18 and older, any sex, with Cardiac Insufficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare in vivo platelet and leukocyte activation and phenotype before and after Left ventricular assist device (LAVD) implantation

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Blood sampling

Trials testing the same drug.

Other University Hospital, Toulouse trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03306017.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing